1 / 4

Indian Inhaler Market Size, Share and Forecast to 2025

Indian Inhaler Market Size, Share & Trends Analysis Report by Device (Metered Dose Inhaler, Dry Powdered Inhaler, and Nebulizer), by Type (Preventive Inhaler, Reliever Inhaler, and Long Acting Bronchodilators Inhaler), by Application (Asthma and Chronic Obstructive Pulmonary Disease (COPD)), by End-User (Homecare and Hospitals and Clinics) and Forecast 2019-2025

larebomrglobal
Télécharger la présentation

Indian Inhaler Market Size, Share and Forecast to 2025

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research Indian Inhaler Market: Industry Growth, Size, Share and Forecast 2019-2025 Request a Free Sample of our Report on Indian Inhaler Market https://www.omrglobal.com/request- sample/indian-inhaler-market ------------------------------------------------------------------------------------ Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 7803040404

  2. Indian inhaler market is anticipated to grow at a substantial rate of 7.4% during the forecast period. Major factors that augments the growth of the market include large population base susceptible to asthma and COPD, rising awareness about treatment for asthma and COPD, and significant presence of market players in the country. The Indian inhaler market is segmented on the basis of device, type, application, and end- user. On the basis of device, the market is sub-segmented into metered dosed inhaler, dry powdered inhaler, and nebulizer. The dry powder inhaler is estimated to have largest market share in the Indian inhaler market due to providing easy inhalation solution. Based on the type, preventive, reliever, and long acting bronchodilators inhaler are analyzed. Moreover, on the basis of application, the market has been classified into asthma and COPD diseases. In addition, based on the end-user, homecare and hospitals and clinics have been analyzed. A full Report of Indian Inhaler Market is Available at: https://www.omrglobal.com/industry- reports/indian-inhaler-market Cipla is one of the major companies working in the inhaler market. The company offers products in the field of asthma, COPD, Allergic Rhinitis (AR), Pulmonary Arterial Hypertension (PAH), lung cancer and Idiopathic Pulmonary Fibrosis (IPF). In May 2018, the company established a partnership with MannKind for marketing and distributing Afrezza. It is the only US FDA approved inhaled insulin available for patients suffering from diabetes. In addition, the company in February 2018, has entered into a partnership with Roche Pharma India for healthcare improvement and increasing access of life-changing medicines in India. Request a Free Sample of our Report on Indian Inhaler Market https://www.omrglobal.com/request- sample/indian-inhaler-market The Report covers: Comprehensive research methodology of the Indian inhaler market. This report also includes a detailed and extensive market overview with key analyst insights. An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations. Analysis of regional regulations and other government policies impacting the Indian inhaler market. Insights about market determinants which are stimulating the Indian inhaler market. Detailed and extensive market segments with regional distribution of forecasted revenues. Extensive profiles and recent developments of market players. Visit to know more about Indian Inhaler Market

  3. Indian Inhaler Market Segmentation By Device Metered Dose Inhaler Dry Powder Inhaler Nebulizer By Type Preventive Inhaler Reliever Inhaler Long Acting Bronchodilators Inhaler By Application Asthma Chronic Obstructive Pulmonary Disease (COPD) Indian Inhaler Market by End-User Homecare Hospitals and Clinics Company Profiles 3M Co. Acorda Therapeutics, Inc. Adamis Pharmaceuticals Corp. Adherium Ltd. Aradigm Corp. AstraZeneca PLC Beximo Pharmaceuticals Ltd. Boehringer Ingelheim International GmbH Cipla Ltd. GlaxoSmithKline PLC Koninklijke Philips N.V. MidasCare Pharmaceutical Pvt. Ltd. Novartis AG Omron Healthcare Inc. Sunovion Pharmaceuticals Teva Pharmaceuticals Industries Ltd.

  4. For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report- customization/indian-inhaler-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research- based services. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. AnuragTiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 780-304-0404

More Related